4/17
09:00 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
4/17
09:00 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
4/17
05:17 am
slno
Soleno Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
Low
Report
Soleno Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
4/17
05:17 am
slno
Soleno Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
Low
Report
Soleno Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
4/8
08:03 am
slno
Soleno Therapeutics (SLNO) had its "neutral" rating reaffirmed by HC Wainwright. They now have a $53.00 price target on the stock, down from $100.00.
Low
Report
Soleno Therapeutics (SLNO) had its "neutral" rating reaffirmed by HC Wainwright. They now have a $53.00 price target on the stock, down from $100.00.
4/8
07:16 am
slno
Soleno Therapeutics (SLNO) was downgraded by Robert W. Baird from "strong-buy" to "hold".
Low
Report
Soleno Therapeutics (SLNO) was downgraded by Robert W. Baird from "strong-buy" to "hold".
4/8
06:06 am
slno
Soleno Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Low
Report
Soleno Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
4/8
06:06 am
slno
Soleno Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Low
Report
Soleno Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
4/7
09:40 am
slno
Soleno Therapeutics (SLNO) had its "peer perform" rating reaffirmed by Wolfe Research.
Low
Report
Soleno Therapeutics (SLNO) had its "peer perform" rating reaffirmed by Wolfe Research.
4/7
09:40 am
slno
Soleno Therapeutics (SLNO) had its "peer perform" rating reaffirmed by Wolfe Research.
Low
Report
Soleno Therapeutics (SLNO) had its "peer perform" rating reaffirmed by Wolfe Research.
4/7
09:37 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
4/7
09:37 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
4/7
05:20 am
slno
Soleno Therapeutics downgraded to Hold from Buy at Stifel
Low
Report
Soleno Therapeutics downgraded to Hold from Buy at Stifel
4/6
04:26 pm
slno
Soleno downgraded to Perform from Outperform at Oppenheimer
Low
Report
Soleno downgraded to Perform from Outperform at Oppenheimer
4/6
04:26 pm
slno
Soleno downgraded to Perform from Outperform at Oppenheimer
Low
Report
Soleno downgraded to Perform from Outperform at Oppenheimer
4/6
04:12 pm
slno
Soleno Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
Low
Report
Soleno Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
4/6
04:12 pm
slno
Soleno Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
Low
Report
Soleno Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
4/6
02:08 pm
slno
Soleno Therapeutics downgraded to Neutral from Outperform at Baird
Low
Report
Soleno Therapeutics downgraded to Neutral from Outperform at Baird
4/6
02:08 pm
slno
Soleno Therapeutics downgraded to Neutral from Outperform at Baird
Low
Report
Soleno Therapeutics downgraded to Neutral from Outperform at Baird
4/6
12:24 pm
slno
Soleno Therapeutics downgraded to Hold from Buy at Laidlaw
Low
Report
Soleno Therapeutics downgraded to Hold from Buy at Laidlaw
4/6
12:24 pm
slno
Soleno Therapeutics downgraded to Hold from Buy at Laidlaw
Low
Report
Soleno Therapeutics downgraded to Hold from Buy at Laidlaw
4/6
10:22 am
slno
Soleno Therapeutics (SLNO) had its "neutral" rating reaffirmed by Cantor Fitzgerald. They now have a $53.00 price target on the stock, down from $123.00.
Low
Report
Soleno Therapeutics (SLNO) had its "neutral" rating reaffirmed by Cantor Fitzgerald. They now have a $53.00 price target on the stock, down from $123.00.
4/6
10:16 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
4/6
08:24 am
slno
Soleno Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
Low
Report
Soleno Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
3/18
12:06 pm
slno
Rating for SLNO
Low
Report
Rating for SLNO